Primary systemic mycosis
MONDO:0000308A systemic mycosis that arises from infection in an immunologically normal host.
8 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
-
Can one Mega-Dose of an antifungal beat a deadly infection in AIDS patients?
Disease control Recruiting nowThis phase III trial is testing whether a single high dose (10 mg/kg) of liposomal amphotericin B can safely and effectively treat disseminated histoplasmosis, a serious fungal infection, in adults with AIDS. The standard treatment requires two weeks of daily infusions. The study…
Phase: PHASE3 • Sponsor: Federal University of Health Science of Porto Alegre • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
New hope for rare brain fungus: experimental drug olorofim tested
Disease control Recruiting nowThis study tests a drug called olorofim in people recently diagnosed with coccidioidal meningitis, a rare fungal infection of the brain and spinal cord. About 12 participants will take olorofim and be followed for 6 months to see if it is safe and helps control the infection. The…
Phase: PHASE2 • Sponsor: Fariba Donovan • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Eye injection shows promise for rare Fungal-Related blindness
Disease control Recruiting nowThis study tests whether faricimab (Vabysmo), an FDA-approved eye injection for other retinal diseases, can safely treat abnormal blood vessel growth in the eye caused by presumed ocular histoplasmosis syndrome. About 25 adults with this condition will receive an initial injectio…
Phase: PHASE4 • Sponsor: Cincinnati Eye Institute, Southwest Ohio • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Scientists dig into why some people get severe valley fever
Knowledge-focused Recruiting nowThis study looks at people with severe or hard-to-treat Valley Fever, a lung infection caused by a fungus found in the southwestern U.S. Researchers want to understand why some people get seriously ill by studying their immune systems and genetics. Up to 400 participants will giv…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Jul 30, 2026 00:00 UTC
-
New rapid test could speed up sepsis diagnosis in ER
Knowledge-focused Recruiting nowThis study is testing a new rapid diagnostic device called In-Dx to quickly identify infections and antibiotic resistance in emergency patients with suspected sepsis. Researchers will compare the device's results to standard lab cultures using stored samples from 2,500 patients. …
Sponsor: Michigan State University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC